A cancer-killing virus injected into pancreatic tumors stopped them growing in three patients, with one stable a year on, offering a breakthrough against the deadly disease. The post Cancer-Killing Virus Stops Pancreatic Tumors From Growing in First Three Patients appeared first on Happilynews.

Patients choose top-rated cancer hospitals for proven outcomes, but the best facilities aren't always the most obvious.

June 2 (Reuters) - Legend Biotech's experimental therapy showed early signs that its approach of generating disease-fighting cells within patients may work for a type of blood cancer, sending shares of the company up nearly 30%.

Regimen showed benefit in advanced head and neck cancer

Celcuity Inc. (NASDAQ:CELC) is one of the best high short interest stocks with highest upside potential. On May 14, Celcuity announced amendments to its Phase 3 VIKTORIA-2 clinical trial, which evaluates gedatolisib as a first-line treatment for hormone receptor-positive,

Researchers at MUSC Hollings Cancer Center have developed a machine learning tool to identify cancer patients who may be at high risk for financial toxicity – the financial stress and hardship that can accompany a cancer diagnosis and treatment.

Sciensus, a leading European life sciences organisation focused on accelerating patients’ access to life-saving medicines, and Rare Patient Voice, a Konovo company, today announced the presentation of data at the 2026 ASCO Annual Meeting showing that people living with rare cancers may face a distinct and heavier treatment access burden than the wider cancer population in Europe.